[go: up one dir, main page]

DE69636046D1 - Verbindungen und Verfahren zur Immuntherapie und Diagnose von Tuberkulose - Google Patents

Verbindungen und Verfahren zur Immuntherapie und Diagnose von Tuberkulose

Info

Publication number
DE69636046D1
DE69636046D1 DE69636046T DE69636046T DE69636046D1 DE 69636046 D1 DE69636046 D1 DE 69636046D1 DE 69636046 T DE69636046 T DE 69636046T DE 69636046 T DE69636046 T DE 69636046T DE 69636046 D1 DE69636046 D1 DE 69636046D1
Authority
DE
Germany
Prior art keywords
tuberculosis
compounds
diagnosis
methods
immunotherapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69636046T
Other languages
English (en)
Other versions
DE69636046T2 (de
Inventor
Steven G Reed
Yasir A W Skeiky
David C Dillon
Antonio Campos-Neto
Raymond L Houghton
Thomas S Vedvick
Daniel R Twardzik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27541835&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69636046(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of DE69636046D1 publication Critical patent/DE69636046D1/de
Application granted granted Critical
Publication of DE69636046T2 publication Critical patent/DE69636046T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69636046T 1995-09-01 1996-08-30 Verbindungen und Verfahren zur Immuntherapie und Diagnose von Tuberkulose Expired - Lifetime DE69636046T2 (de)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US620874 1984-06-15
US52343695A 1995-09-01 1995-09-01
US523436 1995-09-01
US53363495A 1995-09-22 1995-09-22
US533634 1995-09-22
US62087496A 1996-03-22 1996-03-22
US65968396A 1996-06-05 1996-06-05
US659683 1996-06-05
US68057496A 1996-07-12 1996-07-12
US680574 1996-07-12

Publications (2)

Publication Number Publication Date
DE69636046D1 true DE69636046D1 (de) 2006-05-24
DE69636046T2 DE69636046T2 (de) 2006-11-23

Family

ID=27541835

Family Applications (4)

Application Number Title Priority Date Filing Date
DE69636487T Expired - Lifetime DE69636487T2 (de) 1995-09-01 1996-08-30 Zusammensetzungen zur Immuntherapie und Diagnose von Tuberculosis
DE69630457T Expired - Lifetime DE69630457T2 (de) 1995-09-01 1996-08-30 Verbindungen zur immunotherapie und diagnose von tuberkulose
DE69636046T Expired - Lifetime DE69636046T2 (de) 1995-09-01 1996-08-30 Verbindungen und Verfahren zur Immuntherapie und Diagnose von Tuberkulose
DE69637879T Expired - Lifetime DE69637879D1 (de) 1995-09-01 1996-08-30 Verbindungen und Verfahren zur Immuntherapie und Diagnose von Tuberkulose

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DE69636487T Expired - Lifetime DE69636487T2 (de) 1995-09-01 1996-08-30 Zusammensetzungen zur Immuntherapie und Diagnose von Tuberculosis
DE69630457T Expired - Lifetime DE69630457T2 (de) 1995-09-01 1996-08-30 Verbindungen zur immunotherapie und diagnose von tuberkulose

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69637879T Expired - Lifetime DE69637879D1 (de) 1995-09-01 1996-08-30 Verbindungen und Verfahren zur Immuntherapie und Diagnose von Tuberkulose

Country Status (24)

Country Link
EP (5) EP1203817B9 (de)
JP (5) JP4382160B2 (de)
KR (1) KR100433750B1 (de)
CN (1) CN1117149C (de)
AT (5) ATE323165T1 (de)
AU (1) AU727602B2 (de)
BR (2) BR9612997B1 (de)
CA (3) CA2230885C (de)
CY (2) CY2570B1 (de)
CZ (3) CZ300953B6 (de)
DE (4) DE69636487T2 (de)
DK (4) DK1347055T3 (de)
ES (4) ES2324529T3 (de)
HK (1) HK1059282A1 (de)
HU (2) HU225979B1 (de)
IL (1) IL123506A (de)
MX (1) MX9801638A (de)
NO (4) NO324372B1 (de)
NZ (1) NZ319377A (de)
PL (1) PL186774B1 (de)
PT (4) PT851927E (de)
SI (1) SI0851927T1 (de)
TR (5) TR200806258T2 (de)
WO (1) WO1997009428A2 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6641814B1 (en) 1997-04-02 2003-11-04 Statens Serum Institut Nucleic acids fragments and polypeptide fragments derived from M. tuberculosis
US6991797B2 (en) 1993-07-02 2006-01-31 Statens Serum Institut M. tuberculosis antigens
US6290969B1 (en) * 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6458366B1 (en) 1995-09-01 2002-10-01 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6592877B1 (en) 1995-09-01 2003-07-15 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
TR199901569T2 (xx) * 1996-10-11 2000-12-21 Corixa Corporation T�berk�lozun te�hisi i�in bile�ikler ve y�ntemler.
US6627198B2 (en) 1997-03-13 2003-09-30 Corixa Corporation Fusion proteins of Mycobacterium tuberculosis antigens and their uses
US6544522B1 (en) 1998-12-30 2003-04-08 Corixa Corporation Fusion proteins of mycobacterium tuberculosis antigens and their uses
US6350456B1 (en) 1997-03-13 2002-02-26 Corixa Corporation Compositions and methods for the prevention and treatment of M. tuberculosis infection
US6982085B2 (en) 1997-04-02 2006-01-03 Statens Serum Institut TB diagnostic based on antigens from M. tuberculosis
EP1449922B1 (de) * 1997-04-02 2007-08-15 Statens Serum Institut Nukleinsäure- und Polypeptidfragmente von M. tuberculosis
US7037510B2 (en) 1997-04-18 2006-05-02 Statens Serum Institut Hybrids of M. tuberculosis antigens
US6555653B2 (en) 1997-05-20 2003-04-29 Corixa Corporation Compounds for diagnosis of tuberculosis and methods for their use
US6613881B1 (en) * 1997-05-20 2003-09-02 Corixa Corporation Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
US7087713B2 (en) 2000-02-25 2006-08-08 Corixa Corporation Compounds and methods for diagnosis and immunotherapy of tuberculosis
AU8123898A (en) * 1997-07-16 1999-02-10 Institut Pasteur A polynucleotide functionally coding for the lhp protein from mycobacterium tuberculosis, its biologically active derivative fragments, as well as metho ds usingthe same
EP1029053A1 (de) * 1997-11-10 2000-08-23 Statens Seruminstitut Nukleinsäurefragmente und polypeptide von mycobacterium tuberculosis
EP1484405A1 (de) * 1997-11-10 2004-12-08 Statens Serum Institut Nukleinsäure- und polypeptidfragmente von M. Tuberculosis
HU228354B1 (en) * 1998-04-07 2013-03-28 Corixa Corp Fusion proteins of mycobacterium tuberculosis antigens and their uses
GB9808720D0 (en) * 1998-04-23 1998-06-24 Smithkline Beecham Biolog Novel compounds
CA2348475A1 (en) * 1998-11-04 2000-05-11 Isis Innovation Limited Tuberculosis diagnostic test
US6465633B1 (en) 1998-12-24 2002-10-15 Corixa Corporation Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis
AU2594500A (en) * 1998-12-24 2000-07-31 Corixa Corporation Methods for using mycobacterium tuberculosis molecules as immunological adjuvants
CA2372583C (en) * 1999-05-04 2012-07-10 The Public Health Research Institute Of The City Of New York, Inc. Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines
US7009042B1 (en) * 1999-10-07 2006-03-07 Corixa Corporation Methods of using a Mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of the heterologous proteins
US6316205B1 (en) 2000-01-28 2001-11-13 Genelabs Diagnostics Pte Ltd. Assay devices and methods of analyte detection
EP1542732B1 (de) 2000-06-20 2009-09-16 Corixa Corporation Fusionsproteine aus mycobakterium tuberculosis
AU2003213118A1 (en) 2002-02-15 2003-09-09 Corixa Corporation Fusion proteins of mycobacterium tuberculosis
ITRM20040091A1 (it) 2004-02-19 2004-05-19 Istituto Naz Per Le Malattie Test immunologico rapido per la diagnosi ed il monitoraggio dell'infezione tubercolare.
FI119445B (fi) * 2004-10-29 2008-11-14 Waertsilae Finland Oy Polttomoottorin polttoaineen syöttöjärjestelmän paineen värähtelyn vaimennin
EA012037B1 (ru) 2004-11-16 2009-06-30 Круселл Холланд Б.В. Поливалентные вакцины, содержащие рекомбинантные вирусные векторы
US8470338B2 (en) 2005-04-29 2013-06-25 Glaxosmithkline Biologicals, S.A. Method for preventing or treating M tuberculosis infection
FR2952058B1 (fr) * 2009-10-29 2013-10-04 Centre Nat Rech Scient Procede de ligation native de polypeptides
UA110103C2 (uk) 2010-01-27 2015-11-25 Ґлаксосмітклайн Байолоджікалз С.А. Модифікований туберкульозний антиген
MX344280B (es) 2010-12-14 2016-12-09 Glaxosmithkline Biologicals Sa Composicion antigenica de micobacteria.
FR2971509B1 (fr) * 2011-02-16 2013-02-22 Centre Nat Rech Scient Procede de preparation de peptides par assemblage de multiples fragments peptidiques
CN103290030A (zh) * 2012-02-23 2013-09-11 上海交通大学 一种结核分枝杆菌标志物HtdY的重组蛋白及其制备方法和临床应用
MX376235B (es) * 2012-05-04 2025-03-07 Pfizer Inc Antígenos asociados a próstata y regímenes de inmunoterapia basados en vacuna.
KR102643502B1 (ko) * 2014-04-04 2024-03-06 베스타론 코포레이션 인위적으로 활성화된 펩타이드
GB201513176D0 (en) 2015-07-27 2015-09-09 Glaxosmithkline Biolog Sa Novel methods for inducing an immune response
FR3048286B1 (fr) * 2016-02-26 2021-01-22 Omunis Peptides immunogenes et leur utilisation
CN107304231B (zh) * 2016-04-18 2021-01-01 华中农业大学 一种结核分枝杆菌融合蛋白及应用
GB201614485D0 (en) * 2016-08-25 2016-10-12 Univ Oxford Innovation Ltd Immunogenic composition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2244539A1 (en) * 1973-07-13 1975-04-18 Mitsui Pharmaceuticals Tuberculin active proteins and peptides prepn - from tubercle bacillus
FR2265402A1 (en) * 1974-03-29 1975-10-24 Mitsui Pharmaceuticals Tuberculin active proteins and peptides prepn - from tubercle bacillus
US4876089A (en) * 1984-09-06 1989-10-24 Chiron Corporation Feline leukemia virus protein vaccines
US4751180A (en) 1985-03-28 1988-06-14 Chiron Corporation Expression using fused genes providing for protein product
US4935233A (en) 1985-12-02 1990-06-19 G. D. Searle And Company Covalently linked polypeptide cell modulators
US5075109A (en) 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
US4897268A (en) 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
FR2677365B1 (fr) * 1991-06-07 1995-08-04 Pasteur Institut Proteines de mycobacterium et applications.
US5330754A (en) * 1992-06-29 1994-07-19 Archana Kapoor Membrane-associated immunogens of mycobacteria
DK79793D0 (da) * 1993-07-02 1993-07-02 Statens Seruminstitut Diagnostic test
DK79893D0 (da) * 1993-07-02 1993-07-02 Statens Seruminstitut New vaccine

Also Published As

Publication number Publication date
WO1997009428A2 (en) 1997-03-13
HUP9900902A3 (en) 2001-03-28
DE69630457D1 (de) 2003-11-27
WO1997009428A3 (en) 1997-07-17
CY2570B1 (en) 2008-07-02
KR100433750B1 (ko) 2004-09-01
AU7158696A (en) 1997-03-27
EP1347055A2 (de) 2003-09-24
CN1117149C (zh) 2003-08-06
CA2230885C (en) 2010-02-02
NO980883L (no) 1998-04-27
PT1347055E (pt) 2009-06-19
EP1203817B9 (de) 2006-08-16
JP4324597B2 (ja) 2009-09-02
DK1398379T3 (da) 2007-01-08
HU227778B1 (en) 2012-02-28
CZ300953B6 (cs) 2009-09-23
TR200901109T1 (tr) 2012-02-21
ES2262595T3 (es) 2006-12-01
CN1200147A (zh) 1998-11-25
EP1398379A3 (de) 2004-07-14
JP4324596B2 (ja) 2009-09-02
NZ319377A (en) 2000-01-28
EP1347055B1 (de) 2009-03-18
CA2230885A1 (en) 1997-03-13
DE69637879D1 (de) 2009-04-30
ATE337399T1 (de) 2006-09-15
BR9612997B1 (pt) 2012-01-10
NO20070618L (no) 1998-04-27
CZ297406B6 (cs) 2006-12-13
EP1203817A2 (de) 2002-05-08
JP2009159982A (ja) 2009-07-23
JP2006187292A (ja) 2006-07-20
HK1059282A1 (en) 2004-06-25
TR200403064T2 (tr) 2005-08-22
PT1398379E (pt) 2007-01-31
EP1712628A2 (de) 2006-10-18
JP2001517069A (ja) 2001-10-02
DE69636487T2 (de) 2007-05-03
JP2007228972A (ja) 2007-09-13
PT851927E (pt) 2004-03-31
CZ62898A3 (cs) 1999-10-13
EP1203817A3 (de) 2003-01-29
BR9610262B1 (pt) 2013-11-26
IL123506A (en) 2004-12-15
NO324372B1 (no) 2007-10-01
NO980883D0 (no) 1998-02-27
ATE323165T1 (de) 2006-04-15
NO20070619L (no) 1998-04-27
AU727602B2 (en) 2000-12-14
CA2684425A1 (en) 1997-03-13
TR199800411T1 (xx) 1998-05-21
PL325373A1 (en) 1998-07-20
DK1203817T3 (da) 2006-08-14
CY2612B2 (en) 2010-12-22
DK1347055T3 (da) 2009-06-29
JP2006149406A (ja) 2006-06-15
JP4324618B2 (ja) 2009-09-02
NO20070621L (no) 1998-04-27
EP0851927B1 (de) 2003-10-22
ES2271449T3 (es) 2007-04-16
EP1712628A3 (de) 2007-05-23
IL123506A0 (en) 1998-10-30
PL186774B1 (pl) 2004-02-27
EP1712628B1 (de) 2011-06-22
TR200806258T2 (tr) 2008-10-21
EP1347055A3 (de) 2003-11-26
HUP9900902A2 (hu) 1999-07-28
KR19990044347A (ko) 1999-06-25
BR9610262A (pt) 1999-07-06
SI0851927T1 (en) 2004-02-29
EP0851927A2 (de) 1998-07-08
CA2653566A1 (en) 1997-03-13
CA2653566C (en) 2013-06-25
EP1398379A2 (de) 2004-03-17
ATE513915T1 (de) 2011-07-15
CZ300688B6 (cs) 2009-07-15
EP1203817B1 (de) 2006-04-12
DE69636487D1 (de) 2006-10-05
ES2324529T3 (es) 2009-08-10
DE69636046T2 (de) 2006-11-23
TR200806259T2 (tr) 2008-10-21
ES2210392T3 (es) 2004-07-01
DK0851927T3 (da) 2004-01-26
JP4382160B2 (ja) 2009-12-09
ATE426025T1 (de) 2009-04-15
DE69630457T2 (de) 2004-11-25
NO336288B1 (no) 2015-07-13
HU225979B1 (en) 2008-02-28
EP1398379B1 (de) 2006-08-23
ATE252640T1 (de) 2003-11-15
MX9801638A (es) 1998-05-31
PT1203817E (pt) 2006-08-31

Similar Documents

Publication Publication Date Title
ATE513915T1 (de) Verbindungen und verfahren zur immuntherapie und diagnose von tuberkulose
WO1998016646A3 (en) Compounds and methods for immunotherapy and diagnosis of tuberculosis
WO1998053075A3 (en) Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
WO1999042076A3 (en) Compounds and methods for immunotherapy and diagnosis of tuberculosis
CY1108864T1 (el) Ενωσεις για ανοσοθεραπεια και διαγνωση φυματιωσης και μεθοδοι χρησεις τους
AR010517A1 (es) Compuestos y metodos para la inmunoterapia y diagnostico de tuberculosis

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: CORIXA CORP., WILMINGTON, DEL., US

8364 No opposition during term of opposition